| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |